NasdaqGS:ELVNPharmaceuticals
Enliven Therapeutics (ELVN) Fell Out Of Russell Indexes, But Is The Valuation Already Rich?
Enliven Therapeutics (ELVN) was recently removed from several Russell indexes, including the Russell Microcap and Russell 3000E group. This index reshuffle can influence index fund flows and short term trading dynamics for the stock.
See our latest analysis for Enliven Therapeutics.
Despite the index removals, Enliven Therapeutics has seen strong momentum recently, with a 30 day share price return of 51.17%, a year to date share price return of 227.16%, and a 1 year total shareholder return...